#antibodies

The vaccine, dubbed VIR-1388, is designed to stimulate the production of T cells to fight HIV.

Study findings identify a potential marker that could help identify people at high risk of developing long COVID.

Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.

44% of children treated with two bnAbs maintained viral suppression after stopping antiretrovirals.

A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against COVID-19.

The findings provide a basis for future studies of the immune system’s role in longevity.

Researchers discover antibodies to block common respiratory viruses that put bone marrow and stem cell transplant patients at risk.

Fred Hutch study suggests certain immune cells are the source of antibodies that attack donated organs.

NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.

A single vaccine dose delivered to nose aims to protect children and adults against COVID.

Prior to the rollout of the vaccine, pregnant Black and Latino people were most affected by COVID-19.

Inequality, structural racism and unemployment rates all play a role in the likelihood of preterm births.

Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.

Cancer patients undergoing treatment and those with suppressed immune systems eye the future—and the COVID pandemic’s wane—warily.

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.